Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 53051-53100 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06206499
Laterally Rotated Flap for Soft Tissue Augmentation Around Maxillary Loaded Osseointegrated Dental Implant
NARecruiting
30 participants
Started: Apr 4, 2024 · Completed: Oct 29, 2024
3 conditions1 sponsor1 location
NCT06400849
Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy
NARecruiting
60 participants
Started: Apr 4, 2024 · Completed: Jun 4, 2027
1 condition2 sponsors1 location
NCT06470802
Effectiveness of Familiar Voices and Nature Sounds Among Critically Ill Comatose Patients
NARecruiting
90 participants
Started: Apr 4, 2024 · Completed: Apr 30, 2026
3 conditions1 sponsor2 locations
NCT06354244
Electroacupuncture of Different Treatment Frequency in Chronic Urinary Retention Caused by Lower Motor Neuron Lesions
N/ARecruiting
100 participants
Started: Apr 4, 2024 · Completed: Sep 30, 2024
2 conditions1 sponsor1 location
NCT06317285
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
PHASE2Active, not recruiting
158 participants
Started: Apr 4, 2024 · Completed: Oct 1, 2025
1 condition1 sponsor56 locations
NCT06378411
Development and Application of a Musical Game for Motor Rehabilitation
NARecruiting
45 participants
Started: Apr 4, 2024 · Completed: Oct 31, 2024
2 conditions1 sponsor1 location
NCT05917275
Multi-Omics to Predict the Blood Pressure Response to Antihypertensives
PHASE4Recruiting
96 participants
Started: Apr 4, 2024 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT06363279
Validation of the French ATI Scale and Predisposition to Use Technological Tools in Rehabilitation.
NARecruiting
1,000 participants
Started: Apr 4, 2024 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT06008093
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combination With Chemotherapy Compared With Pembrolizumab in Combination With Chemotherapy in Metastatic NSCLC Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS
PHASE3Recruiting
280 participants
Started: Apr 4, 2024 · Completed: Mar 20, 2031
1 condition1 sponsor105 locations
NCT06211569
Study of the Prevalence of Endometriosis and Adenomyosis
N/ARecruiting
400 participants
Started: Apr 4, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06291909
Small Steps Towards Improving Activity and Sleep Habits to Decrease the Risk of Dementia
NAActive, not recruiting
88 participants
Started: Apr 3, 2024 · Completed: Jan 31, 2027
2 conditions2 sponsors1 location
NCT06378827
Intraoperative Dexmedetomidine and Coronary Artery Bypass Graft Surgery
PHASE2/PHASE3Recruiting
100 participants
Started: Apr 3, 2024 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05879302
Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision
NARecruiting
100 participants
Started: Apr 3, 2024 · Completed: Nov 30, 2025
4 conditions3 sponsors2 locations
NCT06688318
Effectivity of Allogenic Umbilical Cord Mesenchymal Stem Cells Conditioned Media for Osteoarthritis of the Knee Joint
PHASE1/PHASE2Active, not recruiting
11 participants
Started: Apr 3, 2024 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT06631534
Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal Defect
PHASE4Recruiting
30 participants
Started: Apr 3, 2024 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT05442671
iTONE Trial (exercIse Training in pulmONary hypertEnsion) Exercise Program for Pediatric PH
NARecruiting
25 participants
Started: Apr 3, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06108284
Impact of Negative Pressure Ventilation in Patients Hospitalized with Acute Hypercapnic Respiratory Failure
NARecruiting
50 participants
Started: Apr 3, 2024 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT06971276
Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening
N/ARecruiting
101 participants
Started: Apr 3, 2024 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05915377
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
NARecruiting
1,050 participants
Started: Apr 3, 2024 · Completed: Dec 31, 2027
4 conditions4 sponsors2 locations
NCT06316570
Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke
PHASE3Recruiting
1,380 participants
Started: Apr 3, 2024 · Completed: Dec 1, 2026
1 condition1 sponsor66 locations
NCT05505643
Cryoablation vs Lumpectomy in T1 Breast Cancers
NARecruiting
120 participants
Started: Apr 3, 2024 · Completed: Apr 30, 2033
2 conditions3 sponsors1 location
NCT06308549
MyDiaMate For Remission Of Diabetes Distress In Type 1 Diabetes (MyREMEDY)
NAActive, not recruiting
660 participants
Started: Apr 3, 2024 · Completed: Jan 31, 2026
2 conditions5 sponsors4 locations
NCT06333418
Effects of VR and Glass WF Colonoscopy
NANot yet recruiting
135 participants
Started: Apr 3, 2024 · Completed: Jun 8, 2024
1 condition1 sponsor0 locations
NCT06442215
Selection of Surgical Technique in Rectal Cancer
N/ARecruiting
333 participants
Started: Apr 3, 2024 · Completed: Apr 3, 2026
1 condition1 sponsor1 location
NCT06288425
Spatial Transcriptomics in Kidney Transplantation
N/AEnrolling by invitation
500 participants
Started: Apr 3, 2024 · Completed: Jan 1, 2035
2 conditions1 sponsor1 location
NCT05582122
SURVEILLE-HPV: Evaluation of HPV16 Circulating DNA as Biomarker to Detect the Recurrence, in Order to Improve Post Therapeutic Surveillance of HPV16-driven Oropharyngeal Cancers
PHASE2Recruiting
420 participants
Started: Apr 3, 2024 · Completed: Apr 1, 2031
1 condition1 sponsor16 locations
NCT06372509
A Proteomic Analysis for Understanding the Link Between Migraine and Cardiovascular Disease
N/ARecruiting
90 participants
Started: Apr 3, 2024 · Completed: Oct 30, 2025
3 conditions2 sponsors1 location
NCT06051695
A Study to Evaluate the Safety and Efficacy of A2B694, a Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
PHASE1/PHASE2Recruiting
230 participants
Started: Apr 3, 2024 · Completed: Jun 30, 2029
20 conditions2 sponsors11 locations
NCT06229483
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
PHASE3Recruiting
102 participants
Started: Apr 3, 2024 · Completed: Dec 31, 2027
2 conditions2 sponsors1 location
NCT06129604
Pilot Window of Opportunity Trial (POET)
PHASE2Recruiting
10 participants
Started: Apr 3, 2024 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT06312137
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
PHASE3Recruiting
780 participants
Started: Apr 3, 2024 · Completed: Oct 23, 2034
1 condition1 sponsor238 locations
NCT06329401
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
PHASE2Recruiting
300 participants
Started: Apr 3, 2024 · Completed: Apr 30, 2026
1 condition2 sponsors135 locations
NCT06223789
VOLT-AF IDE Clinical Study
NAActive, not recruiting
435 participants
Started: Apr 3, 2024 · Completed: Jan 31, 2026
4 conditions1 sponsor40 locations
NCT06670716
BRIEF COGNITIVE and DELIRIUM ASSESSMENTS in STROKE PATIENTS
N/AActive, not recruiting
60 participants
Started: Apr 3, 2024 · Completed: May 3, 2026
1 condition1 sponsor1 location
NCT06257056
Deep Brain Stimulation for Psychosis
NARecruiting
10 participants
Started: Apr 3, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06351904
A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy
PHASE1Recruiting
72 participants
Started: Apr 3, 2024 · Completed: Aug 31, 2028
1 condition1 sponsor3 locations
NCT06492629
Toripalimab Combined With Chidamide for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma
PHASE2Active, not recruiting
43 participants
Started: Apr 3, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06271252
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
PHASE1Recruiting
81 participants
Started: Apr 3, 2024 · Completed: Apr 12, 2028
14 conditions1 sponsor1 location
NCT06207110
Family, Responsibility, Education, Support, and Health for Food Responsiveness
NARecruiting
280 participants
Started: Apr 3, 2024 · Completed: Jan 1, 2029
1 condition3 sponsors2 locations
NCT06229366
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cancer
PHASE1Recruiting
142 participants
Started: Apr 3, 2024 · Completed: Dec 31, 2032
4 conditions1 sponsor7 locations
NCT06600308
Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies
NARecruiting
60 participants
Started: Apr 3, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06288854
Efficacy of Olanzapine on Weight Gain in Advanced Gynecologic Cancer with Paclitaxel and Carboplatin: a Double Blind, Placebo-controlled Randomized Trial
NARecruiting
48 participants
Started: Apr 3, 2024 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06361329
Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL
PHASE3Recruiting
81 participants
Started: Apr 3, 2024 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06266104
Image Enhanced Endoscopy IBD
NARecruiting
270 participants
Started: Apr 3, 2024 · Completed: Mar 1, 2026
2 conditions1 sponsor1 location
NCT05952648
HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array
NARecruiting
126 participants
Started: Apr 3, 2024 · Completed: Apr 1, 2026
2 conditions2 sponsors4 locations
NCT06265220
AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
PHASE1Recruiting
51 participants
Started: Apr 3, 2024 · Completed: Aug 31, 2027
4 conditions1 sponsor9 locations
NCT06354777
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
N/AActive, not recruiting
312 participants
Started: Apr 3, 2024 · Completed: Dec 30, 2026
1 condition2 sponsors6 locations
NCT07056400
Trial to Improve Fertilization Rate and Embryo Development in Intracytoplasmic Sperm Injection (ICSI) Cycles
NARecruiting
108 participants
Started: Apr 3, 2024 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT06506877
A Cognitive Risk Calculator and Screening Tool for Primary Care Settings
NAEnrolling by invitation
50 participants
Started: Apr 3, 2024 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06305247
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours
PHASE1/PHASE2Recruiting
220 participants
Started: Apr 3, 2024 · Completed: Mar 20, 2028
5 conditions1 sponsor12 locations